Literature DB >> 2391416

Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia.

D Campana1, J Farrant, N Inamdar, A D Webster, G Janossy.   

Abstract

In this study, we applied mAb and heterologous antisera in double marker combinations to investigate the phenotype and the proliferative activity of immature B lineage cells in XLA. Bone marrow (BM) samples from eight male adult patients with no circulating B lymphocytes were studied. The proportions and the phenotype of the earliest identifiable B cell progenitors, expressing nuclear terminal deoxynucleotidyl transferase (TdT), cytoplasmic CD22, and membrane CD19 and CD10 were identical to those observed in normal BM. In XLA these cells represented 1.2% to 22% of BM mononuclear cells; 5% to 42% and 1% to 45% of such cells weakly expressed CD20 and CD37, respectively, and invariably lacked CD13 and CD33. Cytoplasmic mu+ sIg- pre-B cells were seen in low numbers (0.1% to 0.3%) in four samples and were undetectable in the remaining four. Consequently, the ratio TdT+/c mu+ was greater than 100 in five out of eight samples studied in contrast to the less than 10 values seen in normal individuals. The proliferative activity of B lineage progenitor cells was studied by using Ki67 and anti-bromodeoxyuridine mAb. Although the proliferation of TdT+ cells in XLA was comparable with that seen in normal BM samples (24% to 59% of TdT+ were Ki67+ and 11% to 27% incorporated bromodeoxyuridine), this was dramatically reduced in the c mu+ cells (no c mu+, Ki67+ seen in three samples where pre-B cells were observed). Thus, the abnormalities of B cell differentiation in XLA are first seen at the c mu+ pre-B stage and suggest a maturation block in the transition between TdT+, c mu- pre-pre-B cells and c mu+ pre-B cells. The severity of this block may be variable, allowing the generation of a near normal number of pre-B cells in some patients, which nevertheless have a defective proliferative activity. Finally, our study further supports the concept that the effects of the "XLA gene" are confined within the B lineage by demonstrating that the proportions of T cells bearing TCR-alpha beta and TCR-gamma delta in XLA are similar to those seen in normal individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391416

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Genes required for B cell development.

Authors:  Mary Ellen Conley
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

3.  Immunoglobulin variable heavy chain cDNA sequence from a patient with X-linked agammaglobulinemia.

Authors:  F Mortari; H D Ochs; R J Wedgwood; H W Schroeder
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

Review 4.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 6.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

Review 7.  Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.

Authors:  W N Khan
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

8.  The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation.

Authors:  Seoung Hoon Lee; Taesoo Kim; Daewon Jeong; Nacksung Kim; Yongwon Choi
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

9.  Application of carrier testing to genetic counseling for X-linked agammaglobulinemia.

Authors:  R C Allen; R G Nachtman; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

10.  Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital.

Authors:  Jin-Kyong Chun; Taek Jin Lee; Jae Woo Song; John A Linton; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.